CDTX stock · RUN stock

CDTX vs RUN

Cidara Therapeutics Inc (CDTX) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.

Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.

Sunrun Inc (RUN) is a solar company listed on NASDAQ.

Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.

Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.

CDTX currently screens at market cap $6.96B. RUN currently screens at market cap $3.05B and trailing P/E 6.0.

Not investment advice. Open the CDTX and RUN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons